{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:29:58Z","timestamp":1788870598264,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,12,31]],"date-time":"2014-12-31T00:00:00Z","timestamp":1419984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Telethon","award":["GGP09018"],"award-info":[{"award-number":["GGP09018"]}]},{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","award":["15889"],"award-info":[{"award-number":["15889"]}],"id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.biomaterials.2014.12.033","type":"journal-article","created":{"date-parts":[[2015,1,17]],"date-time":"2015-01-17T14:01:31Z","timestamp":1421503291000},"page":"58-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-\u03baB Ligand (RANKL) active domain into the circulation"],"prefix":"10.1016","volume":"46","author":[{"given":"Alfredo","family":"Cappariello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Paone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Maurizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Capulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Rucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Muraca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Teti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2014.12.033_bib1","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrendo.2013.137","article-title":"Osteopetrosis: genetics, treatment and new insights into osteoclast function","volume":"9","author":"Sobacchi","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib2","doi-asserted-by":"crossref","first-page":"516278","DOI":"10.1155\/2014\/516278","article-title":"Stem cells: innovations in clinical applications","volume":"2014","author":"Sutton","year":"2014","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib3","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/med.21322","article-title":"The gap between the physiological and therapeutic roles of mesenchymal stem cells","volume":"34","author":"Galderisi","year":"2014","journal-title":"Med Res Rev"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4252\/wjsc.v6.i2.82","article-title":"Enhancing the efficacy of mesenchymal stem cell therapy","volume":"6","author":"Mastri","year":"2014","journal-title":"World J Stem Cells"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0083-6729(04)67002-6","article-title":"Crystal structure of RANK ligand involved in bone metabolism","volume":"67","author":"Ito","year":"2004","journal-title":"Vitam Horm"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5312\/wjo.v4.i4.186","article-title":"Historically significant events in the discovery of RANK\/RANKL\/OPG","volume":"4","author":"Martin","year":"2013","journal-title":"World J Orthop"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2014.05.015","article-title":"Regulation of cortical and trabecular bone mass by communication between osteoblasts, osteocytes and osteoclasts","author":"Sims","year":"2014","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3109\/08820139.2013.822766","article-title":"The role of cytokines in inflammatory bone loss","volume":"42","author":"Souza","year":"2013","journal-title":"Immunol Invest"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib9","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/jbmr.5650100706","article-title":"Characterization of MCSF-induced proliferation and subsequent osteoclast formation in murine marrow culture","volume":"10","author":"Biskobing","year":"1995","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib10","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1084\/jem.190.12.1741","article-title":"Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors","volume":"190","author":"Arai","year":"1999","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib11","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00109-011-0749-z","article-title":"RANKL\/RANK-beyond bones","volume":"89","author":"Hanada","year":"2011","journal-title":"J\u00a0Mol Med Berl"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib12","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1084\/jem.186.12.2075","article-title":"TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor","volume":"186","author":"Wong","year":"1997","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jb\/mvt049","article-title":"Immunology and bone","volume":"154","author":"Danks","year":"2013","journal-title":"J\u00a0Biochem"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0092-8674(00)00103-3","article-title":"The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development","volume":"103","author":"Fata","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature09387","article-title":"Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer","volume":"468","author":"Schramek","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nature08596","article-title":"Central control of fever and female body temperature by RANKL\/RANK","volume":"462","author":"Hanada","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-0-387-72009-8_2","article-title":"Ectodomain shedding of receptor activator of NF-kappaB ligand","volume":"602","author":"Hikita","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib18","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/ng2076","article-title":"Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL","volume":"39","author":"Sobacchi","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-008-9196-4","article-title":"Infantile malignant, autosomal recessive osteopetrosis: the rich and the poor","volume":"84","author":"Villa","year":"2009","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ajhg.2008.06.015","article-title":"Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations","volume":"83","author":"Guerrini","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib21","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1073\/pnas.96.7.3540","article-title":"Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand","volume":"96","author":"Hsu","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib22","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrrheum.2009.217","article-title":"Osteoimmunology and the effects of the immune system on bone","volume":"5","author":"Takayanagi","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.abb.2014.06.017","article-title":"The great beauty of the osteoclast","volume":"558C","author":"Cappariello","year":"2014","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib24","unstructured":"Osteopetrosis. Consensus guidelines for diagnosis, therapy and follow-up. http:\/\/masonshafferfoundation.org\/wp-content\/uploads\/2012\/06\/Osteopetrosis-Guidelines-2011.pdf."},{"key":"10.1016\/j.biomaterials.2014.12.033_bib25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand","volume":"402","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib26","doi-asserted-by":"crossref","first-page":"10905","DOI":"10.1073\/pnas.200294797","article-title":"Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene","volume":"97","author":"Kim","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib27","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/jbmr.1712","article-title":"Osteopetrosis rescue upon RANKL administration to Rankl(-\/-) mice: a new therapy for human RANKL-dependent ARO","volume":"27","author":"Lo Iacono","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02411252","article-title":"Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function","volume":"34","author":"Minkin","year":"1982","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02405297","article-title":"Assessment of an in\u00a0vivo diffusion chamber method as a quantitative assay for osteogenesis","volume":"36","author":"Bab","year":"1984","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib30","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/jbmr.5650090719","article-title":"Bone formation by marrow osteogenic cells (MBA-15) is not accompanied by osteoclastogenesis and generation of hematopoietic supportive microenvironment","volume":"9","author":"Benayahu","year":"1994","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib31","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1089\/ten.2004.10.1148","article-title":"Biomimetic collagen scaffolds for human bone cell growth and differentiation","volume":"10","author":"Yang","year":"2004","journal-title":"Tissue Eng"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib32","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1292\/jvms.65.549","article-title":"Xenotransplantation of porcine pancreatic endocrine cells to total pancreatectomized dogs","volume":"65","author":"Edamura","year":"2003","journal-title":"J\u00a0Vet Med Sci"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib33","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nm.2452","article-title":"Evidence for osteocyte regulation of bone homeostasis through RANKL expression","volume":"17","author":"Nakashima","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib34","doi-asserted-by":"crossref","first-page":"36846","DOI":"10.1074\/jbc.M606656200","article-title":"Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-kappaB ligand","volume":"281","author":"Hikita","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib35","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0945-053X(97)90025-1","article-title":"Relating matrix metalloproteinase structure to function: why the \u201chemopexin\u201d domain?","volume":"15","author":"Murphy","year":"1997","journal-title":"Matrix Biol"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib36","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ccr.2005.04.013","article-title":"MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL","volume":"7","author":"Lynch","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib37","doi-asserted-by":"crossref","first-page":"13613","DOI":"10.1074\/jbc.274.19.13613","article-title":"Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival","volume":"274","author":"Lum","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib38","article-title":"Surface modification of silicon dioxide, silicon nitride and titanium oxynitride for lactate dehydrogenase immobilization","author":"Saengdee","year":"2014","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib39","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.1158\/0008-5472.CAN-09-4416","article-title":"Shedding of RANKL by tumor-associated MT1-MMP activates Src-dependent prostate cancer cell migration","volume":"70","author":"Sabbota","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib40","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib41","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/jmg.2005.036673","article-title":"Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment","volume":"43","author":"Del Fattore","year":"2006","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.biomaterials.2014.12.033_bib42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bone.2013.09.022","article-title":"ClC-7 expression levels critically regulate bone turnover, but not gastric acid secretion","volume":"58","author":"Supanchart","year":"2014","journal-title":"Bone"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961214012836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961214012836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:05:02Z","timestamp":1758902702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961214012836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":42,"alternative-id":["S0142961214012836"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2014.12.033","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-\u03baB Ligand (RANKL) active domain into the circulation","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2014.12.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}